Semantic Scholar uses AI to extract papers important to this topic.
Alzheimer's disease (AD) is characterized by progressive loss of cognitive function, dementia and altered behavior. Over 30… Expand SummaryAlzheimer’s disease is currently thought to be a complex, multifactorial syndrome, unlikely to arise from a single causal… Expand Eight monomeric congeners, related to the multitarget lead candidate memoquin, were prepared and evaluated at multiple targets to… Expand Lipoic acid (LA) is a natural antioxidant. Its structure was previously combined with that of the acetylcholinesterase inhibitor… Expand Memoquin (1) is a lead compound multitargeted against Alzheimer's disease (AD). It is an AChE inhibitor, free-radical scavenger… Expand The multifunctional nature of Alzheimer's disease (AD) provides the logical foundation for the development of an innovative drug… Expand Novel multitargeted antioxidants 3-6 were designed by combining the antioxidant features, namely, a benzoquinone fragment and a… Expand The present article expands on the study of structure-activity relationships of the novel class of quinone-bearing polyamines, as… Expand The initial transition of amyloid β (1–42) (Aβ42) soluble monomers/small oligomers from unordered/α‐helix to a β‐sheet‐rich… Expand One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disease-modifying therapies is the… Expand